kyvero
Market leaders

THC

Tenet Healthcare Corporation (THC)

Healthcare • Medical Care Facilities

StockNYSEUnited StatesUS88033G4073

286.83 USD -2.10% today Updated 12 Nov 2026 21:14

Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Tenet Healthcare Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.

Price history

Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.

All time

Updated 12 Nov 2026 21:14. Information, not advice. Showing the last 12 months. Create a free account to see the whole history

Results

Next results 10 Feb 2027 in 89 days · 08:00 · estimate 5.30
Last results 6.64 vs 4.68 estimated 29 Oct 2026 · Beat +42.0%
Beat the estimate 12 of 12 0 missed · 0 in line · 12 beats in a row
Average surprise +38.5% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

08 Feb 2024: estimate 1.62 08 Feb 2024: reported 2.68 02/24 30 Apr 2024: estimate 1.44 30 Apr 2024: reported 3.22 04/24 24 Jul 2024: estimate 1.91 24 Jul 2024: reported 2.31 07/24 29 Oct 2024: estimate 2.37 29 Oct 2024: reported 2.93 10/24 12 Feb 2025: estimate 2.83 12 Feb 2025: reported 3.44 02/25 29 Apr 2025: estimate 3.13 29 Apr 2025: reported 4.36 04/25 22 Jul 2025: estimate 2.87 22 Jul 2025: reported 4.02 07/25 28 Oct 2025: estimate 3.35 28 Oct 2025: reported 3.70 10/25 11 Feb 2026: estimate 4.07 11 Feb 2026: reported 4.70 02/26 30 Apr 2026: estimate 4.17 30 Apr 2026: reported 4.82 04/26 23 Jul 2026: estimate 4.26 23 Jul 2026: reported 6.12 07/26 29 Oct 2026: estimate 4.68 29 Oct 2026: reported 6.64 10/26

Estimate Reported: beat Reported: miss In line

Quarterly results

DateEPS estimateEPS reportedSurpriseResult
10 Feb 2027 08:00 5.30 — — Upcoming
29 Oct 2026 06:00 4.68 6.64 +42.0% Beat
23 Jul 2026 16:00 4.26 6.12 +43.5% Beat
30 Apr 2026 06:00 4.17 4.82 +15.7% Beat
11 Feb 2026 06:00 4.07 4.70 +15.6% Beat
28 Oct 2025 06:00 3.35 3.70 +10.5% Beat
22 Jul 2025 06:00 2.87 4.02 +40.1% Beat
29 Apr 2025 06:00 3.13 4.36 +39.2% Beat
12 Feb 2025 06:00 2.83 3.44 +21.5% Beat
29 Oct 2024 06:00 2.37 2.93 +23.6% Beat
24 Jul 2024 06:00 1.91 2.31 +21.1% Beat
30 Apr 2024 06:00 1.44 3.22 +123.7% Beat
08 Feb 2024 06:00 1.62 2.68 +65.6% Beat
30 Oct 2023 16:00 1.20 1.44 +20.4% Beat
31 Jul 2023 16:00 1.25 1.44 +15.3% Beat
25 Apr 2023 06:00 1.15 1.42 +23.6% Beat
09 Feb 2023 06:00 1.23 1.96 +58.8% Beat
20 Oct 2022 16:00 1.22 1.44 +18.1% Beat
21 Jul 2022 16:00 0.80 1.50 +88.7% Beat
20 Apr 2022 16:00 1.06 1.93 +82.0% Beat
07 Feb 2022 16:00 1.49 2.70 +81.0% Beat
20 Oct 2021 16:00 1.08 1.99 +83.9% Beat
21 Jul 2021 16:00 1.07 1.59 +48.0% Beat
19 Apr 2021 21:00 0.71 1.30 +83.9% Beat
09 Feb 2021 16:00 1.81 4.72 +160.8% Beat
20 Oct 2020 16:00 0.24 0.64 +163.2% Beat
03 Aug 2020 16:00 -0.71 1.26 +276.3% Beat
04 May 2020 17:00 0.37 1.28 +248.5% Beat
24 Feb 2020 16:00 0.98 0.99 +0.5% In line
04 Nov 2019 16:00 0.32 0.58 +82.5% Beat
05 Aug 2019 16:00 0.44 0.56 +26.2% Beat
29 Apr 2019 16:00 0.29 0.54 +84.6% Beat
25 Feb 2019 16:00 0.29 0.51 +74.6% Beat
05 Nov 2018 16:00 0.12 0.29 +144.2% Beat
06 Aug 2018 16:00 0.23 0.49 +111.4% Beat
30 Apr 2018 16:00 -0.04 0.57 +1,445.6% Beat
26 Feb 2018 16:00 1.28 1.40 +9.8% Beat
27 Oct 2017 08:00 -0.43 -0.17 +60.0% Beat
07 Aug 2017 16:00 -0.18 -0.17 +5.1% Beat
01 May 2017 16:00 -0.52 -0.27 +48.3% Beat
27 Feb 2017 16:00 0.22 0.06 -72.5% Miss
31 Oct 2016 16:00 0.17 0.16 -8.0% Miss
01 Aug 2016 17:00 0.52 0.38 -26.4% Miss
02 May 2016 16:00 0.34 0.45 +33.8% Beat
22 Feb 2016 16:00 0.34 0.35 +3.4% Beat
02 Nov 2015 16:00 0.28 0.29 +3.4% Beat
03 Aug 2015 16:00 0.44 0.75 +70.0% Beat
04 May 2015 16:00 0.31 0.67 +114.6% Beat
23 Feb 2015 16:00 1.18 0.99 -15.9% Miss
03 Nov 2014 16:00 0.10 0.36 +260.4% Beat

Annual results · USD

YearRevenueChangeNet income Net marginEPSEPS changeFree cash flow
2025 21.3B +3.1% 1.4B 6.6% 15.49 -52.6% 2.5B
2024 20.7B +0.5% 3.2B 15.5% 32.70 +472.7% 1.1B
2023 20.6B +7.2% 611M 3.0% 5.71 +50.7% 1.6B
2022 19.2B — 411M 2.1% 3.79 — 321M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Price history in USD, by month
PeriodOpening priceHighLow Closing priceChangeVolumeDividend
Nov 2026 In progress 275.95 301.44 257.95 286.83 +4.97% 9,546,154
Oct 2026 255.71 278.39 252.12 273.25 +6.92% 15,007,900
Sep 2026 267.15 273.58 248.86 255.56 -3.89% 16,656,300
Aug 2026 257.43 283.05 244.44 265.91 +4.37% 16,333,400
Jul 2026 187.68 262.68 179.91 254.78 +36.19% 32,395,400
Jun 2026 172.96 189.00 157.58 187.08 +6.71% 29,819,100
May 2026 179.11 200.89 171.13 175.32 -1.02% 30,800,700
Apr 2026 189.65 206.48 168.11 177.12 -6.14% 29,446,000
Mar 2026 237.00 247.21 182.00 188.71 -21.17% 22,931,000
Feb 2026 189.73 240.83 186.50 239.39 +26.47% 23,806,700
51 older periods: create a free account to see the whole history

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close
292.97 USD
Market cap
22.8B
5-year average yield
2.21%
Last dividend
0.0267 USD · 13 Mar 2000
Exchange
NYSE
Country
United States
Sector
Healthcare
Industry
Medical Care Facilities
Currency
USD

Dividends

Ex-dividend datePer share
13 Mar 20000.0267 USD
16 Aug 19930.3200 USD
17 May 19930.3200 USD
12 Feb 19930.3200 USD
8 older dividends: create a free account to see them

Why this score

How the score is made up
Part of the scorePointsWhy
Business growth Yearly growth of revenue and of earnings per share. 15.5 / 25
  • Revenue growth of 3.6% a year
  • Earnings per share growth of 59.9% a year
Quality Return on equity, net margin and how stable the margins are. 16.5 / 25
  • ROE of 42%
Financial strength Net debt against operating earnings, interest cover and free cash flow. 15.0 / 20
  • Net debt is 2.1× EBITDA
  • Free cash flow yield of 8.8%
Valuation Free cash flow yield and the P/E against its sector. 15.0 / 15
  • P/E 8.5 against 30.6 for its sector
Analysts How far the analysts' average target is from today's price. 5.5 / 10
  • Analysts' target is +7% from the price

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A).

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works

Figures

Valuation
FigureValueReading Sector median
P/E (trailing) 8.47× Good 30.56×
P/E (forward) 14.25× Good 14.16×
Price / book 4.24× Weak 3.5×
Price / sales 1.04× Good 3.33×
EV / EBITDA 7.36× Good 11.19×
Free cash flow yield 8.8% Good 2.1%
Quality
FigureValueReading Sector median
Gross margin 42.5% Good 54.9%
Operating margin 19% Good 5.8%
Net margin 13.1% Good 1.2%
Return on equity 41.7% Good 4.4%
Return on assets 8.7% Good 2.7%
Growth
FigureValueReading Sector median
Revenue growth / year 3.6% Fair 10.1%
EPS growth / year 59.9% Good 10.2%
Financial health
FigureValueReading Sector median
Debt / equity 1.38× Fair 0.4×
Net debt / EBITDA 2.06× Fair 1.46×
Interest cover 4.19× Fair 2.17×
Current ratio 1.59× Good 2.64×
Dividends
FigureValueReading Sector median
Payout of earnings 0% Weak 0%
Dividend growth / year -14.6% Weak 6.5%
Years of rising dividends 0 Weak 1.5

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Similar shares

Follow THC and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in